Viewing Study NCT04543266


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-24 @ 4:25 PM
Study NCT ID: NCT04543266
Status: UNKNOWN
Last Update Posted: 2020-09-11
First Post: 2020-09-08
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning
Sponsor: The University of Hong Kong
Organization:

Study Overview

Official Title: Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning
Status: UNKNOWN
Status Verified Date: 2019-11
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Application Management Team:

PI - Siu Wai Choi; email - htswchoi@hku.hk Delegates - Chui Shan Chu; email: sunshine.c@connect.hku.hk FollowUpUsers - Chui Shan Chu; email:sunshine.c@connect.hku.hk
Detailed Description: Eligibility Criteria:

\- patients were diagnosed with a baseline disease of oral squamous carcinoma.

Exclusion Criteria:

\- N/A

Sample size:

\- \~500 subjects

Source of Data:

\- The data, such as age and medical records, would be obtained from Hospital Authority Clinical Management System (HACMS)

Statistical analysis:

\- machine learning will be applied into analysis plan

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: